Hannibal_Smith
Posted - 1 hour ago
$ATOS Well let's say Mayo Clinic and Pfizer can have a nice chat at ASCO ;) @samirsss you posted a few days ago, how Pfizer acquired Thrillium, by seeing pre clinical data at a conference, if I am not mistaken? Well they can have a very good and clear look at Phase 2 data in a few weeks !
TheChangedBear
Posted - 6 hours ago
$ATOS Hey David! You should bring all your $HEPA earnings and bring them over to $ATOS
Bunster
Posted - 7 hours ago
$ATOS so 10k monday or they get an extension.
Bunster
Posted - 7 hours ago
$ATOS NO week in review due to easter weekend bunnys favorite holiday.
CJ27969
Posted - 7 hours ago
$ATOS this is a great question from @chrundrel Here is some DD I found Hopefully you can open it https://ajronline.org/doi/pdf/10.2214/ajr.140.1.15?download=true
Nailujulian
Posted - 9 hours ago
$ATOS $AZN $LLY $NVS $PFE Some definitions I found for some of the big names involved in the data-release.
1.) "Contract" means a Funding Agreement that is a research and development contract that provides that the contractor perform for the benefit of the Government, with an expectation of completion of the stated research goals and the delivery of a report, data, materials or other product. Generally, Government
contracts are administered under the Federal Acquisition Regulations (FAR), codified at Title 48 Code of Federal Regulations, Chapter 1
2.) "Grant" means a Funding Agreement that is an award of financial assistance which may be provided for support of basic research in a specific field of interest to the funding Federal agency (See 45 CFR Part 74, for grants from the U.S. Public Health Service.) While no specific product is anticipated, the funding agency may review the progress and direction of the funded research.
OKBoomer19
Posted - 9 hours ago
$TPST $ATOS $AVTX @no_noise Appreciate "heads up" on warrants etc. One of my favorite screen moments. Into this clip 1:28 he uses his turkey call https://www.youtube.com/watch?v=DJy4XlObDzA
rigpig
Posted - 9 hours ago
$ATOS - Main key people / companies involved at AACR meeting What do you think will be the outcome? $PFE $LLY $AZN $NVS https://www.abstractsonline.com/pp8/#!/20272/presentation/11540 Session PO.CT02.01 - Phase II Clinical Trials 1 CT205 / 5 - Neoadjuvant (Z)-endoxifen in premenopausal ER+, HER2- breast cancer: Evaluation of the first pharmacokinetic cohort of the EVANGELINE trial M. P. Goetz, Atossa Grant/Contract Pfizer Grant/Contract. Loxo at Lilly Grant/Contract, Travel, Other, consulting with Money to Mayo. Astra Zeneca Other, consulting with Money to Mayo. Novartis Other, consulting with Money to Mayo. Atossa theapeutics Employment. Atossa Therapeutics Grant/Contract. S. Quay, Atossa Therapeutics Employment, Stock, Other Business Ownership, Patent The only company with a patent - Atossa / Dr Quay Wish you all Happy Easter and a blessed year ahead
gordykroo
Posted - 10 hours ago
$ATOS When did Quay start using the "kill" language? Before or after 40 to 80 dosing?
Inserrato
Posted - 11 hours ago
$ATOS quay is euphoric I wouldn't be surprised by a real BO
Fredminish
Posted - 11 hours ago
$ATOS If anyone has good source to rank companies please share. Found dates though... 2024 Reconstitution calendar April-ranking month April is “ranking” month when the largest US companies are lined up to form the preliminary Russell US reconstitution portfolio. In 2024, the rank day will fall on Tuesday, April 30. May- and June-transition months May is the month that the preliminary reconstitution portfolio begins to be communicated to the marketplace. Beginning on May 24, preliminary lists are communicated to the marketplace and updates are provided on May 31, June 7, June 14, June 21 and June 28. The newly reconstituted indexes will take effect after the market close on 28 June 2024.
Fredminish
Posted - 11 hours ago
$ATOS Russell inclusion... anyone have a good way to track rankings? Where is ATOS? # Also, does anyone have the specific timeline of rank day (where they measure market cap), prelim ranking day, recon day (fourth friday in June, June 28th)? Much appreciated.
Miller22
Posted - 11 hours ago
$ATOS The Good Dr is Very Smart !!
Each of the seven US Food and Drug Administration-approved drugs Quay previously developed has been marketed by a company that is not his own, and that's the likely path for (Z)-endoxifen, as well. "We will develop it as if we're going to market it ourselves," he said, but added that all the while they will be assembling the elements needed to appeal to a drugmaker for licensing or acquisition. Those elements include patents, convincing Phase II data, and a Phase III trial design that the FDA has reviewed and indicated could lead to drug approval. "We're going to have Phase II data this year. The next step is to come up with a Phase III design, go to the FDA, and get approvals on those. And obviously, we'll be talking to partners along the way," Quay said.
GreenBook
Posted - 12 hours ago
$ATOS Hope everyone has a good weekend! See you all on Monday!
no_noise
Posted - 12 hours ago
$ATOS like say....endo ...will give u super powers...sterilized ur ass
Nailujulian
Posted - 12 hours ago
$ATOS Each of the seven US Food and Drug Administration-approved drugs Quay previously developed has been marketed by a company that is not his own, and that's the likely path for (Z)-endoxifen, as well. "We will develop it as if we're going to market it ourselves," he said, but added that all the while they will be assembling the elements needed to appeal to a drugmaker for licensing or acquisition. Those elements include patents, convincing Phase II data, and a Phase III trial design that the FDA has reviewed and indicated could lead to drug approval. "We're going to have Phase II data this year. The next step is to come up with a Phase III design, go to the FDA, and get approvals on those. And obviously, we'll be talking to partners along the way," Quay said.
Read the last two sentences for a TLDR.
BOVEN
Posted - 12 hours ago
$ATOS absolutely solid this week. Only way is up. Wouldn’t even dream of selling
DharlMorey2
Posted - 12 hours ago
$ATOS (Reshare this to the newcomers) Quay says we having a data-driven year[1] -- timeline below from Samirsss. More DD on latest catalysts [2], and our pipeline is targeting before/during/after breast cancer which is unique (great acquisition target for $PFE, $AZN , etc.). Not much more I can say -- we're ready for a strong move up on data April 5th, and conference presentation April 10. Russell 2000/3000 inclusion possible soon on preliminary list release on 4/19. [1] https://www.genomeweb.com/Reprint-GW23002AtossaTherapeutics [2] https://www.proactiveinvestors.com/NASDAQ:ATOS/Atossa-Therapeutics-Inc [3] https://atossatherapeutics.com/product-pipeline/ I predict an $AMAM or $VKTX like move!
GSPfedorSilva
Posted - 12 hours ago
$atos
kinostreams
Posted - 12 hours ago
$ATOS 👌
no_noise
Posted - 13 hours ago
$ATOS sometimes I think I have super powers. ..avtx predictions
amiral
Posted - 13 hours ago
$ATOS Really awesome 🤩 “Quay said the company currently has a three-year cash runway and is anticipating a "data-driven" year which will support advancement of (Z)-endoxifen as a monotherapy and inform decisions around development of combination therapies and other cancer indications.”
I really like especially this part "data-driven" year which will support advancement of (Z)-endoxifen as a monotherapy
CJ27969
Posted - 13 hours ago
$ATOS attack never came today. These pigs always know what’s going on before the common folks does. Read into it what you want. 😏. AH PR posts 🤌🏼
no_noise
Posted - 13 hours ago
$ATOS our princess is going to another kingdom...how much are we setting.dowry..king wants a case of Hennessey bonus..
no_noise
Posted - 13 hours ago
$ATOS just buy atos more guys..genome web is huge deal..